• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步化治疗除颤器(CRT-D)与心脏再同步化治疗起搏器(CRT-P):谁需要猝发性心脏死亡保护?

CRT-Pacemaker Versus CRT-Defibrillator Who Needs Sudden Cardiac Death Protection?

机构信息

Service de Cardiologie et Maladies Vasculaires, CHU de Rennes, INSERM, LTSI - UMR 1099, Université de Rennes, 2 rue Henri Le Guilloux, F-35000, Rennes, France.

出版信息

Curr Heart Fail Rep. 2020 Aug;17(4):116-124. doi: 10.1007/s11897-020-00465-z.

DOI:10.1007/s11897-020-00465-z
PMID:32506301
Abstract

PURPOSE OF THE REVIEW

Patients with cardiomyopathy and impaired left ventricular (LV) ejection fraction are at risk of sudden cardiac death (SCD). In selected heart failure patients, cardiac resynchronization therapy (CRT) provides LV reverse remodeling and improves the cellular and molecular function leading to a reduced risk of ventricular arrhythmia and SCD. Consequently, some CRT candidates may not need concomitant ICD therapy. This review aimed at focusing on the residual risk of SCD in patients receiving CRT and discussing the requirement of a concomitant ICD therapy in CRT candidates.

RECENT FINDINGS

New imaging diagnostic tools may be helpful to accurately predict patient with a residual risk of SCD and who required a CRT-D implantation. Recent data highlighted that cardiac computed tomography (CT) or myocardial scar tissue analysis using contrast-enhanced cardiac magnetic resonance (CMR) was able to predict the occurrence of VA in patients with bi-ventricular pacing. Cardiac imaging and specifically myocardial scar analysis seem promising to evaluate the risk of SCD following bi-ventricular pacing and will probably be of great help in the future to accurately identify those who needs concomitant defibrillator's protection.

摘要

目的综述

患有心肌病和左心室射血分数降低的患者有发生心源性猝死(SCD)的风险。在某些心力衰竭患者中,心脏再同步治疗(CRT)可提供左心室逆向重构,并改善细胞和分子功能,从而降低室性心律失常和 SCD 的风险。因此,一些 CRT 候选者可能不需要同时进行 ICD 治疗。本文旨在关注接受 CRT 治疗的患者的 SCD 残余风险,并讨论 CRT 候选者是否需要同时进行 ICD 治疗。

新发现

新的影像学诊断工具可能有助于准确预测 SCD 残余风险高且需要 CRT-D 植入的患者。最近的数据表明,心脏计算机断层扫描(CT)或使用对比增强心脏磁共振(CMR)的心肌瘢痕组织分析能够预测双心室起搏患者室性心律失常的发生。心脏影像学,特别是心肌瘢痕分析,似乎有希望评估双心室起搏后 SCD 的风险,并且可能在未来对准确识别需要同时进行除颤器保护的患者有很大帮助。

相似文献

1
CRT-Pacemaker Versus CRT-Defibrillator Who Needs Sudden Cardiac Death Protection?心脏再同步化治疗除颤器(CRT-D)与心脏再同步化治疗起搏器(CRT-P):谁需要猝发性心脏死亡保护?
Curr Heart Fail Rep. 2020 Aug;17(4):116-124. doi: 10.1007/s11897-020-00465-z.
2
Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.由于起搏诱导性心肌病而升级为心脏再同步治疗的患者发生危及生命的室性心律失常的风险较低:一项长期死因分析。
Europace. 2018 Jan 1;20(1):89-96. doi: 10.1093/europace/euw321.
3
Can cardiac resynchronization therapy be used as a tool to reduce sudden cardiac arrest risk?心脏再同步治疗能否作为降低心源性猝死风险的手段?
Prog Cardiovasc Dis. 2019 May-Jun;62(3):242-248. doi: 10.1016/j.pcad.2019.04.004. Epub 2019 Apr 17.
4
Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy.室性心律失常风险与心肌瘢痕相关,但与心脏再同步治疗反应无关。
Europace. 2020 Sep 1;22(9):1391-1400. doi: 10.1093/europace/euaa142.
5
Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.心脏再同步治疗患者的瘢痕特征预测危及生命的心律失常事件和心源性猝死:GAUDI-CRT 研究。
JACC Cardiovasc Imaging. 2018 Apr;11(4):561-572. doi: 10.1016/j.jcmg.2017.04.021. Epub 2017 Aug 2.
6
Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.利用心肌瘢痕特征预测心脏再同步治疗中的室性心律失常。
Europace. 2012 Nov;14(11):1578-86. doi: 10.1093/europace/eus104. Epub 2012 May 4.
7
Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.心脏再同步治疗中左心室射血分数的正常化与室性心律失常和临床结局的风险:来自多中心自动除颤器植入试验与心脏再同步治疗(MADIT-CRT)试验的结果。
Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9.
8
Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review.心脏再同步治疗的心力衰竭患者心源性猝死风险的时间趋势:一项系统评价
Eur Heart J. 2020 Jun 1;41(21):1976-1986. doi: 10.1093/eurheartj/ehz773.
9
Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.植入型心律转复除颤器治疗非缺血性心肌病患者的疗效:一项随机对照试验的系统评价和荟萃分析。
JACC Clin Electrophysiol. 2017 Sep;3(9):962-970. doi: 10.1016/j.jacep.2017.02.006. Epub 2017 May 31.
10
Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.在 MADIT-CRT 中,那些改善程度超过除颤器指南建议的患者发生室性心律失常事件的风险。
JACC Clin Electrophysiol. 2019 Oct;5(10):1172-1181. doi: 10.1016/j.jacep.2019.08.009. Epub 2019 Oct 2.